Clinical Trial Update: A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED) [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial in obesity was terminated; no trial results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 3 | Status: TERMINATED